|1001 Liberty Ave. , Pittsburgh, PA 15222|
|Fund Manager||Thomas Banks|
|Manager Tenure||6 Years 8 Months|
The Fund s investment objective is to provide long-term growth of capital. The Fund pursues its investment objective of long-term growth of capital by investing at least 80% of its net assets in equity securities issued by non-U.S. small- or mid-capitalization companies. The Fund s investment adviser, Federated Global Investment Management Corp., (the Adviser ) seeks to invest in companies whose stock the Adviser perceives as undervalued relative to their assets or attractively priced relative to their growth prospects. The Fund may invest in companies from both developed and emerging market countries. The Fund may hedge its currency risk by using derivatives such as futures or forward contracts. The Fund may invest in depositary receipts, real estate investment trusts, exchange-traded funds, derivative contracts (such as options, swaps and futures contracts) and hybrid investments (such as notes linked to underlying securities or indices) in order to implement its investment strategy. For example, the Fund may use derivative contracts or hybrid instruments to increase or decrease the portfolio s exposure to the investment(s) underlying the derivative or hybrid instrument in an attempt to benefit from changes in the value of the underlying investment(s), to obtain premiums from the sale of derivative contracts, or to realize gains from trading a derivative contract. There can be no assurance that the Fund s use of derivative contracts or hybrid instruments will work as intended. Derivative investments made by the Fund are included within the Fund s 80% policy, as described below, and are calculated at market value. The Fund will invest its assets so that at least 80% of its net assets (plus any borrowings for investment purposes) are invested in small- or mid-capitalization companies. The Fund will notify shareholders at least 60 days in advance of any change in its investment policy that would permit the Fund to invest, under normal circumstances, less than 80% of its net assets (plus any borrowings for investment purposes) in investments in small- or mid-capitalization companies. For purposes of this limitation, small- or mid-capitalization companies will normally be defined as companies with market capitalizations similar to the constituents of the Fund s benchmark, the MSCI ACWI ex USA SMID Cap Index. As of November 30, 2020, the capitalization of companies included in the MSCI ACWI ex USA SMID Cap Index ranged from approximately $19.8 million to $40.2 billion. Such definition will be applied at the time of investment and the Adviser will not be required to sell a stock because a company s market capitalization has grown larger than the range of small- or mid-capitalization stocks in the MSCI ACWI ex USA SMID Cap Index.
|Asset Type||% Of Allocation|
|Total Net Assets||5.04 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$250|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 06/30/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 06/30/2021|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|EVOG.ST||EVOLUTION GAMING GROUP AB||1.86%|
|GOIXX||FEDERATED HERMES GOVMT OBLI||1.46%|
|LONN.S||LONZA GROUP - REG||1.39%|
|DNP.WA||DINO POLSKA SA||1.38%|
|0669.HK||TECHTRONIC INDUSTRIES CO||1.27%|
|PVOXX||FEDERATED HERMERS INSTNL PRIM||1.23%|
Join the Action Alerts PLUS Community today!
Micron topped analysts' fourth quarter expectations but provided tepid outlook for the first quarter.
Wolfe Research upgraded Chewy to outperform, saying a drop in net new customer additions should reverse in fiscal 2022.
Ahead of third-quarter earnings season, James 'Rev Shark' Deporre has some thoughts on what investors should be thinking about.
Gogo, Huntsman, Thor Industries, United Natural Foods and Sonoma Pharmaceuticals are five top stock gainers for Tuesday.
Stocks end sharply lower Tuesday as Wall Street contends with rolling blackouts in China, record high energy prices in Europe and gas line-ups in Britain.
Aurora Cannabis had a tough quarter, but Cowen analysts still expect strong growth margins in 2022.